Each week, our Money Morning experts recommend which stocks to buy across a range of sectors. Then we collect the latest picks in one roundup, in case you missed any.
Last week, Money Morning Chief Investment Strategist Keith Fitz-Gerald identified four companies set to soar from the integration of human bodies and technology.
Defense & Tech Specialist Michael A. Robinson shared a biotech stock at the forefront of a burgeoning $53 billion market.
Resource Specialist Peter Krauth delivered a gold exchange-traded fund (ETF) that will benefit from a surging U.S. dollar.
And there are four more picks ahead. You can find them all here in our newest compilation of which stocks to buy now.
Which Stocks to Buy Now: 10 New Picks
Human augmentation is one of Money Morning Chief Investment Strategist Keith Fitz-Gerald's most profitable "Unstoppable Trends." The sector is expanding at a compound annual growth rate (CAGR) of 43.52%. It will be worth hundreds of billions of dollars just five years from now. One of his longtime favorites, Ekso Bionics Holding (OTCBB: EKSO), has returned 25% since he recommended it last October - and it's still a buy. In fact, Fitz-Gerald recently raised his EKSO price projection to $21.85 a share - a tremendous 1,555% gain from today's opening price of $1.32. Here are three other human augmentation companies that will smash the S&P 500 this year ...
- In vitro diagnostics (IVD) - a type of medical testing that takes place outside the body, as in a test tube - is becoming one of the most profitable biotech subsectors. According to ResearchandMarkets, the IVD market was worth $53.3 billion in 2013. With a CAGR of 5.34%, it's projected to hit $74.65 billion by 2020. And Money Morning Defense & Tech Specialist Michael A. Robinson recommended one biotech firm specializing in "molecular diagnostics," the fastest-growing area of the IVD market. Its stock is up 32.9% in the last month and trades at a huge discount right now...
- According to Money Morning Resource Specialist Peter Krauth, "capital controls" occurring in Europe may spread to the United States. A capital control is a measure taken by a national government to limit the flow of foreign capital in and out of the nation's economy. They usually include taxes, tariffs, or other legislative restrictions. The dollar has risen 19% in the last eight months, bringing a lot of foreign capital into the United States. That means the Federal Reserve could impose capital controls any day now. One of the best ways to prepare is to invest in gold, which has been rising despite the strong dollar. Krauth shared a gold ETF with $216 million in assets that's jumped 2.6% in the last week...
[epom key="ddec3ef33420ef7c9964a4695c349764" redirect="" sourceid="" imported="false"]
- Fear of rising interest rates has had a negative effect on U.S. markets. The Dow Jones, S&P 500, and Nasdaq had a three-day losing streak last week - respectively shedding 1.24%, 1.50%, and 1.57%. But Chief Investment Strategist Keith Fitz-Gerald sees this as an opportunity. Last week's collapse spotlighted three "must-have" investments that are resistant to further market losses. That's because these companies sell services and products that are indispensable to humanity. One of them provides water and wastewater services to about 14 million people in North America and boasts a 2.3% yield. Here are all three low-risk, high-yield stocks...
- Real estate investment trusts (REITs) are dominating the dividend market right now. REITs are companies that own or finance real estate properties, such as office buildings and apartments. They offer an average yield of 4.1% - higher than two of the top five highest-yielding stocks on the Dow. And they've been on a tear lately. The S&P U.S. REIT Index has jumped 11.8% since October. We found an ETF with the best holdings in the REIT industry, which is set to hit a $1 trillion market cap within the next few years...
More on High-Yield Investments: Eighteen master limited partnership (MLP) IPOs last year raised more than $6.4 billion. That growth is expected to continue in 2015 - with or without an interest rate hike. Here are three new offerings that will hit the market this year - plus one of our favorite MLPs to buy right now...
Follow me on Twitter: @AlexMcGuire92